Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli

Clinical Microbiology and Infection

Volumn 12, Issue 10, 2006, Pages 1034-1036

  Soto, S M ^a   Smithson, A ^a   Horcajada, J P ^a   Martinez, J A ^a   Mensa, J P ^a   Vila, J ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Aerobactin; Biofilm formation; Escherichia coli; Relapse; Urinary tract infection; Yersiniabactin

Indexed keywords

AEROBACTIN; ANTIBIOTIC AGENT; BACTERIAL DNA; CYTOTOXIC NECROTIZING FACTOR 1; FIMBRIA PROTEIN; FIMBRIA PROTEIN A; FIMBRIA PROTEIN P; FIMBRIA PROTEIN S; HEMOLYSIN; TOXIN AUTOTRANSPORTER; UNCLASSIFIED DRUG; VIRULENCE FACTOR; YERSINIABACTIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTER INFECTION; FEMALE; FREQUENCY ANALYSIS; HUMAN; IN VITRO STUDY; LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; REINFECTION; RELAPSE; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ESCHERICHIA COLI;

EID: 33748295529     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01543.x     Document Type: Article

References (11)

1. Svanborg C, Goldaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997; 11: 513-529.
2. Madersbacher S, Thalhammer F, Marberger M et al. Pathogenesis and management of recurrent urinary tract infection in women. Curr Opin Urol 2000; 10: 29-33.
3. Vila J, Marcos MA, Jiménez de Anta MT. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J Med Microbiol 1996; 44: 482-489.
4. Gautom RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 1997; 35: 2977-2980.
5. Johnson JR, Stell A. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-272.
6. Danese PN, Pratt LA, Dove SL, Kolter R. The outer membrane protein, antigen-43, mediates cell-to-cell interactions within Escherichia coli biofilms. Mol Microbiol 2000; 37: 424-432.
7. Silhauy TJ, Berman ML, Enquist LW. Experiments with gene fusions. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1984; 217-219.
8. Finer G, Landau D. Pathogenesis of urinary tract infections with normal female anatomy. Lancet Infect Dis 2004; 4: 631-635.
9. Mulvey MA, Schilling JD, Martínez JJ, Hultgren SJ. Bad bugs and beleagured bladders: Interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci USA 2000; 97: 8829-8835.
10. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infection. Science 2003; 301: 105-107.
11. Johnson JR, O'Bryan TT, Delavari P et al. Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. J Infect Dis 2001; 183: 1508-1517.